CD151 drives cancer progression depending on integrin α3β1 through EGFR signaling in non-small cell lung cancer.
Saved in:
| Title: | CD151 drives cancer progression depending on integrin α3β1 through EGFR signaling in non-small cell lung cancer. |
|---|---|
| Authors: | Zhu, Jianjie1,2,3 (AUTHOR), Cai, Tingting1,2 (AUTHOR), Zhou, Jieqi1,2 (AUTHOR), Du, Wenwen1,2 (AUTHOR), Zeng, Yuanyuan1,2,3 (AUTHOR), Liu, Ting1,2 (AUTHOR), Fu, Yulong1,2 (AUTHOR), Li, Yue1,2 (AUTHOR), Qian, Qian4 (AUTHOR), Yang, Xiuwei H.5 (AUTHOR), Li, Qinglin6 (AUTHOR) qinglin200886@126.com, Huang, Jian-an1,2,3 (AUTHOR) huang_jian_an@163.com, Liu, Zeyi1,2,3 (AUTHOR) liuzeyisuda@163.com |
| Source: | Journal of Experimental & Clinical Cancer Research (17569966). 6/9/2021, Vol. 40 Issue 1, p1-18. 18p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
